13D/13G Filings - RA Capital Management, L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...8, 9, 10, 11, 12, ...24, 25, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-08-11
5:05 pm
Purchase
2023-08-10 13D Vor Biopharma Inc.
VOR
RA Capital Management, L.P. 22,780,343
33.700%
20,198increase
(+0.09%)
Filing
History
2023-08-11
5:01 pm
Sale
2023-08-09 13D 89bio, Inc.
ETNB
RA Capital Management, L.P. 12,874,814
16.700%
-2,084decrease
(-0.02%)
Filing
History
2023-08-09
5:00 pm
Sale
2023-08-09 13D DICE Therapeutics, Inc.
DICE
RA Capital Management, L.P. 0
0.000%
-7,877,862decrease
(Position Closed)
Filing
History
2023-08-01
4:30 pm
Purchase
2023-06-08 13G NewAmsterdam Pharma Company N.V.
NAMS
RA Capital Management, L.P. 9,333,333
11.300%
5,000,000increase
(+115.38%)
Filing
History
2023-07-25
4:31 pm
Purchase
2023-07-21 13D Acumen Pharmaceuticals, Inc.
ABOS
RA Capital Management, L.P. 14,981,618
25.900%
5,207,067increase
(+53.27%)
Filing
History
2023-07-06
4:32 pm
Purchase
2023-06-26 13G Talaris Therapeutics, Inc.
TALS
RA Capital Management, L.P. 233,318
5.500%
233,318increase
(New Position)
Filing
History
2023-07-06
4:30 pm
Purchase
2023-06-26 13G Unicycive Therapeutics, Inc.
UNCY
RA Capital Management, L.P. 3,470,689
9.990%
3,470,689increase
(New Position)
Filing
History
2023-06-27
5:00 pm
Purchase
2023-06-26 13D Aerovate Therapeutics, Inc.
AVTE
RA Capital Management, L.P. 8,293,148
30.000%
29,166increase
(+0.35%)
Filing
History
2023-06-21
5:00 pm
Purchase
2023-06-18 13D DICE Therapeutics, Inc.
DICE
RA Capital Management, L.P. 7,877,862
16.500%
217,247increase
(+2.84%)
Filing
History
2023-06-12
5:00 pm
Sale
2023-06-08 13D Satsuma Pharmaceuticals, Inc.
STSA
RA Capital Management, L.P. 0
0.000%
-5,944,252decrease
(Position Closed)
Filing
History
2023-06-05
4:31 pm
Purchase
2023-05-25 13G 4D Molecular Therapeutics, Inc.
FDMT
RA Capital Management, L.P. 2,789,721
6.700%
2,789,721increase
(New Position)
Filing
History
2023-05-30
5:00 pm
Purchase
2023-05-25 13D Icosavax, Inc.
ICVX
RA Capital Management, L.P. 5,985,843
12.500%
206,496increase
(+3.57%)
Filing
History
2023-05-15
5:02 pm
Sale
2023-05-15 13G Travere Therapeutics, Inc.
TVTX
RA Capital Management, L.P. 0
0.000%
-3,984,681decrease
(Position Closed)
Filing
History
2023-05-15
5:01 pm
Sale
2023-05-15 13G DA32 Life Science Tech Acquisition Corp.
DALS
RA Capital Management, L.P. 0
0.000%
-1,500,000decrease
(Position Closed)
Filing
History
2023-05-15
5:01 pm
Sale
2023-05-15 13G ARYA Sciences Acquisition Corp V
ARYE
RA Capital Management, L.P. 0
0.000%
-1,000,000decrease
(Position Closed)
Filing
History
2023-04-18
4:30 pm
Purchase
2009-02-28 13D Satsuma Pharmaceuticals, Inc.
STSA
RA Capital Management, L.P. 5,944,252
17.900%
30,000increase
(+0.51%)
Filing
History
2023-04-10
5:05 pm
Purchase
2023-03-30 13G NanoString Technologies, Inc.
NSTGQ
RA Capital Management, L.P. 2,577,373
5.500%
2,433,473increase
(+1691.09%)
Filing
History
2023-04-10
5:01 pm
Purchase
2023-04-06 13D Climb Bio, Inc.
CLYM
RA Capital Management, L.P. 13,163,071
48.800%
11,112increase
(+0.08%)
Filing
History
2023-04-10
5:00 pm
Purchase
2023-04-06 13G Ascendis Pharma A/S
ASND
RA Capital Management, L.P. 9,967,172
17.400%
3,009,993increase
(+43.26%)
Filing
History
2023-03-30
5:08 pm
Purchase
2023-03-28 13G GH Research PLC
GHRS
RA Capital Management, L.P. 5,561,118
10.700%
662,745increase
(+13.53%)
Filing
History
Goto Prev, 0, 1, ...8, 9, 10, 11, 12, ...24, 25, Next